Algernon Pharmaceuticals Inc., of Vancouver, British Columbia, said it closed its private placement offering of special warrants, which included the exercise of the overallotment option, pursuant to which the company issued about 19.6 million special warrants at a price of 35 cents each, for aggregate gross proceeds of about $6.9 million. The offering was led by Mackie Research Capital Corp. as sole agent and bookrunner.

No Comments